Akne-mycin 2000
Akne-mycin 2000 is a medicine authorised by Swissmedic under authorisation number 48142. The authorisation holder is Almirall AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 September 1987 and the authorisation is valid without a time limit. ATC code D10AF02 places the medicine in the group Anti-acne preparations.
| Authorisation number | 48142 |
|---|---|
| Name | Akne-mycin 2000 |
| Full name | Akne-mycin 2000, Salbe |
| Authorisation holder | Almirall AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D10AF02 |
| First authorisation | 04 September 1987 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Akne-mycin 2000, Salbe | B | 04 September 1987 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 25 | g | D10AF02 | 10.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Akne-mycin 2000 authorised in Switzerland?
Yes. Akne-mycin 2000 is authorised by Swissmedic under authorisation number 48142, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Akne-mycin 2000 have?
Akne-mycin 2000 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Akne-mycin 2000?
The authorisation holder is Almirall AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.